D-0341-2018 Class II Terminated
FDA drug recall D-0341-2018 was initiated by PD-Rx Pharmaceuticals, Inc. on Jan 25, 2018 and is designated Class II. Reason for recall: CGMP deviations. The recall status is terminated (terminated May 7, 2020). Affected quantity: 7174 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 7, 2018
- Initiation Date
- Jan 25, 2018
- Termination Date
- May 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7174 bottles
Product description
PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60
Reason for recall
CGMP deviations.
Distribution pattern
Nationwide
Code information
Lots: K16E92 Exp. 5/31/18; B17A87 Exp. 5/31/18; E17A51 Exp. 5/31/18; L16B59 Exp. 1/31/18; K16E01 Exp. 5/31/18; A17F21 Exp. 5/31/18; B17D71 Exp. 5/31/18; D17E92 Exp. 5/31/18; J16D13 Exp. 1/31/18; A17D63 Exp. 5/31/18; E17A18 Exp. 5/31/18; F17B87 Exp. 5/31/18; C17C58 Exp. 5/31/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0341-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026